Priced at $17 a share, Canadian medicinal marijuana producer Tilray is expected to make its market debut on Thursday in the U.S. markets.
The company will be trading under the ticker symbol TLRY and is expected to debut on the NASDAQ.
Tilray is being recognized as the first pure-play marijuana IPO in the United States as well as the third marijuana stock to list on a major exchange in the nation.
While Canopy Growth (CGC) made its debut on the NYSE in May and Cronos Group listed on the NASDAQ in February, neither are considered to be an IPO technically.
Tilray has filed a registration statement for the proposed offering last month and applied to list on the Nasdaq Global Select Market.
The company announced last week that it would have 9 million shares with an expected price range of $14-$16 a piece. This offering could result in producing $144 million.
